ACWI vs XBI
iShares MSCI ACWI ETF vs SPDR S&P Biotech ETF
- • ACWI has the lower expense ratio at 0.32% vs 0.35% for XBI.
- • ACWI pays a higher dividend yield (1.44%).
Side-by-side metrics
| Metric | ACWI | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.32% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.44% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $32.28B | $10.92B |
YTD return | 11.21% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.97 | 1.01 |
P/E ratio | 20.85 | — |
Last price | $157.73 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
ACWI top holdings
| AAPL | Apple Inc | 5.00% |
| NVDA | NVIDIA Corp | 4.65% |
| MSFT | Microsoft Corp | 3.64% |
| AMZN | Amazon.com Inc | 2.30% |
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 1.76% |
| GOOGL | Alphabet Inc Class A | 1.62% |
| AVGO | Broadcom Inc | 1.46% |
| META | Meta Platforms Inc Class A | 1.33% |
| GOOG | Alphabet Inc Class C | 1.28% |
| TSLA | Tesla Inc | 1.13% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About ACWI
ACWI (iShares MSCI ACWI ETF) is Global equities including US and developed/emerging markets. Managed by iShares, the fund carries $32.3B in assets under management, an expense ratio of 0.32%, a dividend yield of 1.44%. Its largest holding is Apple Inc (AAPL), which represents 5.0% of the portfolio. Real Estate is the fund's largest sector exposure at 1.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.